Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.
D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002455:Cell Division; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D006863:Hydrogen-Ion Concentration; D010447:Peptide Hydrolases / Q000378:metabolism*; D013936:Thymidine / Q000494:pharmacology
D010447:Peptide Hydrolases; D001973:Bromodeoxyuridine; D013936:Thymidine